These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24225041)

  • 1. [Generic drugs and the consumption trends of antihypertensives in Morocco].
    Berrada El Azizi G; Ahid S; Ghanname I; Belaiche A; Hassar M; Cherrah Y
    Therapie; 2013; 68(5):303-12. PubMed ID: 24225041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in antihypertensives use among Moroccan patients.
    Berrada El Azizi G; Ahid S; Ghanname I; Belaiche A; Hassar M; Cherrah Y
    Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1067-73. PubMed ID: 22585420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    El Azizi GB; Ahid S; Ghannam I; Belaiche A; Hassar M; Cherrah Y
    Therapie; 2013; 68(5):303-12. PubMed ID: 27393184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Consumption analyze of the antihypertensive drugs in Morocco: period 1991-2005].
    Soussi-Tanani D; Alaoui K; Belaiche A; Hassar M; Cherrah Y
    Therapie; 2008; 63(2):129-33. PubMed ID: 18561887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health care too costly? Saving more than 10 million euros in 2 months!].
    Rappert B
    MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
    [No Abstract]   [Full Text] [Related]  

  • 6. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of hypertension. Cost conscious prevention of complications].
    Kolloch RE
    MMW Fortschr Med; 2003 Nov; 145(47):64. PubMed ID: 14725042
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review.
    Park C; Wang G; Durthaler JM; Fang J
    Am J Prev Med; 2017 Dec; 53(6S2):S131-S142. PubMed ID: 29153114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do generic drugs help control expenditure on hypertension? Apropos of a case].
    García AJ; Martos F; Martín A; Sánchez F
    Gac Sanit; 2004; 18(2):137-44. PubMed ID: 15104975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance].
    Laux G; Szecsenyi J; Miksch A; Grün B; Gutscher A; Grün B; Rosemann T; Kühlein T
    Med Klin (Munich); 2009 Feb; 104(2):108-13. PubMed ID: 19242661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern analysis and variations in the utilization of antihypertensive drugs in Taiwan: a six-year study.
    Huang LY; Shau WY; Chen HC; Su S; Yang MC; Yeh HL; Lai MS
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):410-9. PubMed ID: 23426547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries.
    Godman B; Wettermark B; Miranda J; Bennie M; Martin A; Malmström RE
    Int J Clin Pract; 2013 Sep; 67(9):853-62. PubMed ID: 23560825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors influencing anti-asthmatic generic drug consumption in Morocco: 1999-2010.
    Ghanname I; Ahid S; Berrada G; Belaiche A; Hassar M; Cherrah Y
    Springerplus; 2014; 3():192. PubMed ID: 24790832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Medicare Savings From Generic Substitution and Therapeutic Interchange of ACE Inhibitors and Angiotensin-II-Receptor Blockers.
    Growdon ME; Sacks CA; Kesselheim AS; Avorn J
    JAMA Intern Med; 2019 Dec; 179(12):1712-1714. PubMed ID: 31380893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
    Corp EV; Antoniou S; Wright PG; Khachi H; Vercaeren S; Wald DS
    QJM; 2009 Dec; 102(12):843-9. PubMed ID: 19828644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of cost variation in different brands of antihypertensive agents.
    Moharana AK; Khurana S; Lal A
    J Assoc Physicians India; 1998 Jun; 46(6):573-4. PubMed ID: 11273270
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing step-therapy programs:a step in the right direction.
    Gleason PP
    J Manag Care Pharm; 2007 Apr; 13(3):273-5. PubMed ID: 17407393
    [No Abstract]   [Full Text] [Related]  

  • 19. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
    Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.